Skip to main content
Clinical Trials/NCT03954847
NCT03954847
Unknown
Not Applicable

Clinical Significance of Computer Aided Image Analysis in Treatment Response Evaluation of Lung Cancer

Wuhan Union Hospital, China1 site in 1 country1,000 target enrollmentJanuary 1, 2012
ConditionsLung Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lung Cancer
Sponsor
Wuhan Union Hospital, China
Enrollment
1000
Locations
1
Primary Endpoint
Overall survival
Last Updated
6 years ago

Overview

Brief Summary

The investigators will evaluate the utility of computer aided image analysis in lung cancer with the aim of predicting treatment response and prognosis.

Detailed Description

Tumor biological behavior is the fundamental cause of heterogeneous prognosis. The features found on medical images are also reflections of the tumor biological behavior. However, the limitations in spatial and intensity resolution of the naked eye are two inevitable shortcomings of image interpretation by naked eyes, resulting in subjective and limited analyses of images. Computer aided image analyses such as radiomic analysis and machine learning methods are emerging as promising image interpretation methods. The natural advantage of the unlimited spatial and intensity resolution of computers can overcome the shortcomings of visual inspection with the naked eye. Moreover, the massive computing power of computer is also far greater than that of humans. This study will focus on the application of computer aided analysis in predicting treatment response and prognosis in lung cancer.

Registry
clinicaltrials.gov
Start Date
January 1, 2012
End Date
December 31, 2020
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Wuhan Union Hospital, China
Responsible Party
Principal Investigator
Principal Investigator

Yang Jin

Professor

Wuhan Union Hospital, China

Eligibility Criteria

Inclusion Criteria

  • Patients \>= 18 years old
  • Pathological diagnosis of NSCLC between 2012 and 2019;
  • PET/CT or CT examination before any cancer-specific treatment;

Exclusion Criteria

  • A time interval between treatment and image examination greater than 1 month;
  • A history of other malignancies

Outcomes

Primary Outcomes

Overall survival

Time Frame: 2012-2021

The interval between the date of diagnosis and death

Secondary Outcomes

  • Progression free survival(2012-2021)

Study Sites (1)

Loading locations...

Similar Trials